Stay updated on Pfizer Press Releases
Sign up to get notified when there's something new on the Pfizer Press Releases page.

Latest updates to the Pfizer Press Releases page
- Check2 days agoChange DetectedShifts focus from oncology news to vaccine updates and accessibility: adds Pfizer/BioNTech vaccine content with dates and an Accessibility Statement, and removes the BRAFTOVI cancer news item.SummaryDifference13%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now includes the FDA approval of Pfizer and BioNTech’s COMIRNATY® vaccine for specific age groups, while the previous mention of Astellas and Pfizer’s XTANDI™ research has been removed.SummaryDifference13%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now includes information about the significant survival benefits of PADCEV™ Plus KEYTRUDA™ for bladder cancer patients, while a previous announcement regarding Pfizer's licensing agreement has been removed.SummaryDifference10%
- Check38 days agoChange DetectedThe webpage has updated its financial reporting for Pfizer, replacing the first-quarter results with stronger second-quarter results and an increased EPS guidance for 2025.SummaryDifference8%
- Check46 days agoChange DetectedThe page now includes a positive opinion from the CHMP regarding a COVID-19 vaccine adaptation by Pfizer and BioNTech, while a previous entry about a significant improvement in bladder cancer treatment has been removed.SummaryDifference10%
- Check53 days agoChange DetectedThe webpage has added a significant announcement regarding Pfizer's licensing agreement with 3SBio, while previous content about the 2025 shareholder meeting results has been removed.SummaryDifference10%
Stay in the know with updates to Pfizer Press Releases
Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.